Search Results 71-80 of 16512 for crohns%20disease

  1. The microbiome, fecal microbiota transplants and inflammatory bowel disease - Mayo Clinic

    ... inflammatory bowel disease ... chronic intestinal inflammation. Patients with IBD , either Crohn's disease (CD) or ulcerative colitis ...

  2. Early Mayo Clinic research finds hope in stem cell therapy for perianal fistulas in patients with Crohn's disease

    As many as 26% of people with Crohn's disease will develop perianal fistulas. Most often, it starts with an infection within the anal gland and often progresses ...

  3. Study to Assess Limited Magnetic Resonance Imaging in the Surveillance of Crohn's Disease - Mayo Clinic

    Study to Assess Limited Magnetic Resonance Imaging in the Surveillance of Crohn's Disease · Overview · Participation eligibility · Participating Mayo Clinic ...

  4. A Study to Develop a Patient-reported Outcome Tool for Symptomatic Small Bowel Stricturing Crohn’s Disease (CD) - Mayo Clinic

    A Study to Develop a Patient-reported Outcome Tool for Symptomatic Small Bowel Stricturing Crohn's Disease (CD) ... symptoms, and related experiences of patients ...

  5. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) · Overview · Participation eligibility · Participating Mayo Clinic ...

  6. Low-dose CT Enterography for Pediatric Crohn’s Disease Diagnosis and Staging - Mayo Clinic

    The study will estimate observer performance for Low-dose CT enterography ( LD-CTE) for detection of ileal inflammation due to Crohn's disease. It will also ...

  7. Expert explains how inflammatory bowel disease, irritable bowel syndrome differ - Mayo Clinic News Network

    Diarrhea; Rectal bleeding; Bloating; Occasional constipation; Gas; Urgent bowel movements; Cramping abdominal pain. Symptoms of inflammatory bowel disease may ...

  8. Mayo Clinic Inflammatory Bowel Disease Repository

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult ...

  10. A Study to Evaluate Posaconazole to Treat Genetically-defined Patients with Active Crohn's Disease - Mayo Clinic

    The purpose of this study is to evaluate the effects of oral antifungal treatment with posaconazole on disease activity and the burden of Malassezia spp. in CD ...